Dr. Morteza Dowlatshahi, MD

  • Morgan Hill, CA
  • Radiation oncologist
NPI1437112158PAC ID8426183880
Medicare services, 2024
260
Medicare patients, 2024
65
Part D claims, 2024
51
MIPS score, 2024
100
Industry payments
$9,236
Practice address
18511 Mission View Dr, Morgan Hill, CA 95037
Practice phone
Call (408) 729-4673
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Cancer Care Institute

Morgan Hill, California

See all 3 affiliations

Find Dr. Dowlatshahi's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Morteza Dowlatshahi is a radiation oncologist in Morgan Hill, California

Dr. Dowlatshahi practices at Cancer Care Institute in Morgan Hill, California.

Dr. Dowlatshahi's NPI, 1437112158, was assigned on April 11, 2006. Dr. Dowlatshahi graduated from University of Kansas School of Med (KC/Wich/Sal) in 1994. Dr. Dowlatshahi holds California license A55256.

NPI and contact details
Medicare PAC ID
8426183880
NPI enumeration date
April 11, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(408) 729-4673
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
58
Medical school graduation
1994

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Morteza Dowlatshahi practices at Cancer Care Institute in Morgan Hill, California

Dr. Dowlatshahi's primary practice is Cancer Care Institute, at 18511 Mission View Dr, Morgan Hill, CA 95037 in Santa Clara County. The practice phone is (408) 729-4673.

  • Cancer Care Institute
    18511 Mission View Dr, Morgan Hill, CA 95037 · Santa Clara CountyPhone(408) 729-4673

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Morteza Dowlatshahi is affiliated with 2 sites of care and 1 medical group

Dr. Dowlatshahi's primary practice is Cancer Care Institute in Morgan Hill, California. The medical group on file is Cancer Care Institute. Dmand AI also links Dr. Dowlatshahi to 1 more group practice or clinic, named with a free account.

See all 3 affiliations for Dr. Dowlatshahi

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Morteza Dowlatshahi's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dowlatshahi practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Cancer Care InstituteAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Dowlatshahi practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Morteza Dowlatshahi is one of 685 radiation oncologists in California

Radiation oncology is Dr. Dowlatshahi's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Dowlatshahi is licensed in California.

Specialties and state licenses

  • Radiation oncology, CaliforniaPrimaryLicense A55256 · taxonomy 2085R0001X

Radiation oncologists near Dr. Dowlatshahi

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

685radiation oncologists in California
2radiation oncologists in Morgan Hill

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Morteza Dowlatshahi billed Medicare for 260 services in 2024

CMS data shows 260 Medicare services from Dr. Dowlatshahi across 6 procedure codes in 2024, for 65 Medicare patients. Medicare paid $33,713 for them. Every service was in an office.

Medicare services, 2024260
Medicare patients65
Paid by Medicare$33,713
Procedure codes6

Dr. Dowlatshahi's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 2342024: 19815%
Office and hospital visits
2023: 612024: 622%
Other services
2023: 2212024: 0100%

Dr. Dowlatshahi compared with the California median for radiation oncologists, 2024

  • Dr. Dowlatshahi
  • California median
Medicare services
260vs 1,44482% below
Medicare patients
65vs 16460% below
Part D claims
14vs 3256% below

Medians across 633 radiation oncologists in California with Dmand AI profiles that report each measure.

Dr. Dowlatshahi's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Dowlatshahi

Need commercial claims for Dr. Dowlatshahi?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Dowlatshahi and other radiation oncologists in California.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Morteza Dowlatshahi treated 65 Medicare patients in 2024, average age 78

CMS counts 65 Medicare patients who saw Dr. Dowlatshahi in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have cancer, and 75% have high blood pressure. 57% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dowlatshahi's median patient age at 72, with 58% women.

Medicare patients, 202465
Average age78
Average risk score1.77
Also on Medicaid57%

Dr. Dowlatshahi's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Dowlatshahi's Medicare patients by sex, 2024

  • Women3655%
  • Men2945%

Chronic conditions among Dr. Dowlatshahi's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Diabetes45%
  5. Arthritis32%
  6. Chronic kidney disease29%
  7. Ischemic heart disease23%
  8. Atrial fibrillation22%

Share of Medicare patients with each condition. A patient can have several.

Dr. Dowlatshahi's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women58%
  • Men41%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Morteza Dowlatshahi wrote 51 Medicare Part D claims in 2024

In 2024, Dr. Dowlatshahi wrote 51 Medicare Part D claims for 26 patients. 90% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $574 in total drug cost. In 2023, CMS named 42 claims across 2 drugs.

Part D claims, 202451
Drugs named by CMS1
Total drug cost$574
Part D patients26

Dr. Dowlatshahi's Part D claims by kind of drug, 2024

  • Generic46 claims90%
  • Brand-name and other5 claims10%

Dr. Dowlatshahi's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 422024: 1467%

Drugs named by CMS: 1 in 2024, 2 in 2023.

See all prescribing by Dr. Dowlatshahi

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Morteza Dowlatshahi scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Dowlatshahi for performance year 2024, reported as part of a group. Dr. Dowlatshahi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Dowlatshahi's MIPS scores, performance year 2024

  • 100of 100Final score
  • 95of 100Quality
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find radiation oncologists like Dr. Dowlatshahi by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Morteza Dowlatshahi received $9,236 in industry payments from 2016 to 2025

CMS Open Payments shows 383 general payments to Dr. Dowlatshahi from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,138.

General payments to Dr. Dowlatshahi by program year, 2016 to 2025

General payments to Dr. Dowlatshahi by kind, 2016 to 2025

$9.2Kin total
  • Food and beverage$8,72694%
  • Education$5106%

Companies that paid Dr. Dowlatshahi the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Dowlatshahi

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Morteza Dowlatshahi graduated from University of Kansas School of Med (KC/Wich/Sal)

Dr. Dowlatshahi graduated from University of Kansas School of Med (KC/Wich/Sal) in 1994.

  1. Medical schoolUniversity of Kansas School of Med (KC/Wich/Sal)

Source: Dmand AI Professional Profile Data

Sources for Dr. Morteza Dowlatshahi's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Morteza Dowlatshahi

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Morteza Dowlatshahi's NPI number?

Dr. Morteza Dowlatshahi's NPI number is 1437112158. It was assigned on April 11, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Morteza Dowlatshahi?

Dr. Morteza Dowlatshahi is a radiation oncologist in Morgan Hill, California. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Morteza Dowlatshahi practice?

Dr. Dowlatshahi practices at 18511 Mission View Dr, Morgan Hill, CA 95037. Dr. Dowlatshahi's primary practice is Cancer Care Institute in Morgan Hill, California. Dmand AI also links Dr. Dowlatshahi to 1 group practice or clinic.

What is Dr. Morteza Dowlatshahi's office phone number?

The practice phone on file for Dr. Dowlatshahi is (408) 729-4673.

What is Dr. Morteza Dowlatshahi's medical license number?

Dr. Dowlatshahi holds California license A55256.

What medical group is Dr. Morteza Dowlatshahi part of?

Dr. Dowlatshahi is linked to Cancer Care Institute.

Does Dr. Morteza Dowlatshahi accept Medicare?

Yes. CMS data shows Dr. Dowlatshahi billed Medicare for 260 services in 2024, and Dr. Dowlatshahi accepts Medicare assignment.

What is Dr. Morteza Dowlatshahi's MIPS score?

Dr. Dowlatshahi's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.

How many Medicare patients does Dr. Morteza Dowlatshahi see?

CMS counts 65 Medicare patients who saw Dr. Dowlatshahi in 2024, with an average age of 78.

What services does Dr. Morteza Dowlatshahi bill to Medicare?

In 2024, Dr. Dowlatshahi's most billed Medicare services were radiation oncology (77427), radiation oncology (77336) and office visit, established patient (99214).

Show 4 more questionsShow fewer questions

Where did Dr. Morteza Dowlatshahi go to medical school?

Dr. Dowlatshahi graduated from University of Kansas School of Med (KC/Wich/Sal) in 1994.

What drugs does Dr. Morteza Dowlatshahi prescribe most?

In 2024 Medicare Part D data, Dr. Dowlatshahi's most prescribed drugs by claims were Lidocaine HCl Viscous.

Has Dr. Morteza Dowlatshahi received payments from drug or device companies?

CMS Open Payments shows $9,236 in general payments to Dr. Dowlatshahi from 48 companies from 2016 to 2025. The largest total came from Janssen Pharmaceuticals, Inc.

How long has Dr. Morteza Dowlatshahi been practicing?

Dr. Dowlatshahi graduated from medical school in 1994, 32 years ago.

Selling to radiation oncology practices?

See radiation oncologists in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)